Explore the latest in vaccination, including recent advances in child and adult immunization and studies of vaccine refusal and safety.
This Viewpoint assesses the ethical and practical implications of a 2016 resolution by the American Academy of Pediatrics on the acceptability of dismissing vaccine-refusing parents from pediatric clinical practices.
This national survey study investigates changes in the proportion of hospitals requiring health care personnel to receive annual influenza vaccinations in 2013 and 2017 and compares the change among Veterans Affairs and non–Veterans Affairs hospitals.
This Viewpoint discusses the low rates of vaccination for human papillomavirus in the United States and the role that otolaryngologists can play in improving public health policy about this vaccination.
This cluster randomized clinical trial evaluates the effect of a 5-component health care professional human papillomavirus vaccine communication intervention on adolescent human papillomavirus vaccination.
This matched cohort study investigates if children after receiving an autism spectrum disorder diagnosis obtain their remaining scheduled vaccines and compares their vaccination patterns with those of younger siblings of children without autism spectrum disorder.
In this Viewpoint, Anthony Fauci and colleagues review modern technological advances that facilitate acceleration of vaccine development in response to new and emerging viral disease threats, and argue for investment in surveillance in developing countries to expedite pathogen identification and jump-start the vaccine development process.
This nested case-control study compares cumulative vaccine antigen exposure through the first 23 months of life among children with vs without non–vaccine-targeted infections between 24 and 47 months of age.
This Medical Letter review compares a newly approved 2-dose hepatitis B virus vaccine that uses a synthetic oligonucleotide immunostimulatory adjuvant, and is licensed for use in adults, with other commercially available 3-dose vaccines.
This modeling study based on randomized clinical trial data assesses the cost-effectiveness of the adjuvanted herpes zoster subunit vaccine.
This Viewpoint proposes a strategy to reduce the underimmunization of pediatric transplant recipients.
This cost-effectiveness analysis compares 4 strategies for pediatric emergency department–based influenza vaccine: offering vaccine to all patients, only to patients younger than 5 years, only to high-risk patients (all ages), or to no patients.
In this Viewpoint, Anthony Fauci and colleagues review rapid research responses to recent infectious disease outbreaks as a way of emphasizing the strategies and collaborations necessary to prepare for a next unknown pandemic.
This Viewpoint examines strategies for vaccinating travelers against yellow fever given recent vaccine shortages and global yellow fever outbreaks.
Customize your JAMA Network experience by selecting one or more topics from the list below.